Proper inactivation of HIF-1α may contribute to the reduction in inflammasomes and cell damage and to enhanced mitochondrial function through the transcriptional regulations and post-modification of target molecules in neurodegenerative diseases, such as stroke, TBI, and AD. This evidence concerns the gene HIF1A and Alzheimer disease.